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SUMMARY
Treslin helps to trigger the initiation of DNA replication by promoting integration of Cdc45 into 
the replicative helicase. Treslin is a key positive-regulatory target of cell cycle control 
mechanisms; activation of Treslin by cyclin-dependent kinase is essential for the initiation of 
replication. Here we demonstrate that Treslin is also a critical locus for negative regulatory 
mechanisms that suppress initiation. We found that the checkpoint-regulatory kinase Chk1 
associates specifically with a C-terminal domain of Treslin (designated TRCT). Mutations in the 
TRCT domain abolish binding of Chk1 to Treslin and thereby eliminate Chk1-catalyzed 
phosphorylation of Treslin. Significantly, abolition of the Treslin-Chk1 interaction results in 
elevated initiation of chromosomal DNA replication during an unperturbed cell cycle, which 
reveals a function for Chk1 during a normal S-phase. This increase is due to enhanced loading of 
Cdc45 onto potential replication origins. These studies provide important insights into how 
vertebrate cells orchestrate proper initiation of replication.
INTRODUCTION
In eukaryotic cells, duplication of the genome depends upon the intricate, stepwise assembly 
of protein complexes onto origins of DNA replication (Sclafani and Holzen, 2007; Siddiqui 
et al., 2013; Tanaka and Araki, 2013). Initially, the origin recognition complex (ORC) and 
Cdc6 associate with potential origins and thereupon recruit Cdt1 and the mini-chromosome 
maintenance (MCM) complex. The MCM complex serves as the core of the replicative 
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helicase that unwinds the DNA strands for replication. A key regulatory juncture in 
replication involves the concerted binding of additional proteins to the MCM complex to 
form the mature, activated version of the helicase. In particular, the Cdc45 and GINS 
proteins associate with the MCM proteins and thereby form the CMG (Cdc45-MCM-GINS) 
complex, which corresponds to the fully constituted helicase.
In vertebrates, integration of Cdc45 and GINS with the MCMs depends upon TopBP1 and a 
recently discovered TopBP1-binding protein called Treslin (also known as Ticrr)(Kumagai 
et al., 2010; Sansam et al., 2010). Importantly, formation of the TopBP1-Treslin complex 
requires phosphorylation of Treslin by the S-phase cyclin-dependent kinase (S-CDK)(Boos 
et al., 2011; Kumagai et al., 2011). Consequently, this phosphorylation helps to explain how 
the cell cycle control system dictates the timing of S-phase. An analogous situation exists in 
budding yeast where phosphorylation of the Treslin homologue Sld3 by S-CDK is also 
critical for replication (Labib, 2010; Siddiqui et al., 2013; Tanaka and Araki, 2013).
Treslin is a relatively large protein (220 kD) that is approximately three times bigger than 
yeast Sld3. Thus, Treslin may have acquired new properties that allow it to meet the more 
complex demands of higher eukaryotes. To obtain further insight into established and 
potentially novel functions of Treslin, we have engaged in a search for Treslin-interacting 
proteins in human cells. These studies resulted in the identification of Chk1, an effector 
kinase in checkpoint control mechanisms. Chk1 is best known for its role in blocking 
activation of CDKs in cells with incompletely replicated or damaged DNA (Perry and 
Kornbluth, 2007; Toledo et al., 2011).
Significantly, further studies have indicated that Chk1 also plays a role during a seemingly 
normal cell cycle. For example, a number of observations have implicated Chk1 in the 
control of replication during an unperturbed S-phase (Maya-Mendoza et al., 2007; McIntosh 
and Blow, 2012; Miao et al., 2003; Syljuasen et al., 2005). The mechanism by which Chk1 
exerts these effects is obscure. Chk1 also participates in suppressing endoreplication in 
trophoblast stem (TS) cells (Ullah et al., 2011). Moreover, Chk1 appears to function in the 
system that monitors correct attachment of chromosomes to the mitotic spindle (Zachos et 
al., 2007). Overall, these observations suggest that Chk1 has diverse roles in cell cycle 
regulation, which may help to explain why it is essential for viability (Liu et al., 2000). 
Therefore, it will be important to understand how cells control the participation of Chk1 in 
these varied functions.
In this report, we have investigated the molecular mechanism and functional consequences 
of the Treslin-Chk1 interaction in both human cells and Xenopus egg extracts. We show that 
Chk1 negatively regulates the Treslin-mediated loading of Cdc45 onto chromatin and 
thereby serves to antagonize the initiation of replication. These studies provide an important 
new perspective on how vertebrate cells control the initiation of DNA replication through 
opposing negative and positive regulatory mechanisms. Furthermore, these experiments 
reveal the mechanistic basis for a critical function of Chk1 apart from its role in checkpoint 
responses to damaged DNA.
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RESULTS
Chk1 Is a Treslin-interacting Protein
To search for Treslin-interacting proteins, we expressed various tagged versions of Treslin 
in human 293T cells, re-isolated these polypeptides, and then analyzed associated proteins 
by mass spectrometry (Figure 1A). For these experiments, we produced recombinant full-
length human Treslin with both S-peptide and 3X-FLAG tags at the C-terminal end 
(designated Treslin-SF). We also prepared tagged fragments corresponding to residues 
1-1257 and 1253-1909 of the protein. The 1-1257 fragment can restore DNA replication to 
Treslin-depleted cells (Kumagai et al., 2011). Thus, the remaining C-terminal domain of 
Treslin may have some regulatory role. For this study, we focused on proteins that might 
bind selectively to this area.
We identified Chk1 as a protein that associated with full-length Treslin and the C-terminal 
1253-1909 fragment, but not the N-terminal 1-1257 fragment (see Experimental Procedures 
and Table S1). To validate these findings, we subjected S-protein pulldowns from cells to 
immunoblotting with anti-Chk1 antibodies (Figure 1B). We likewise observed binding of 
Chk1 to both the full-length protein and C-terminal fragment. Conversely, as expected from 
previous studies, TopBP1 associated with the N-terminal but not C-terminal fragment 
(Kumagai et al., 2011). We also performed reciprocal immunoprecipitation experiments in 
human cells; we detected the presence of Treslin in anti-Chk1 immunoprecipitates and Chk1 
in anti-Treslin immunoprecipitates, respectively (Figure 1C). Treatment with ethidium 
bromide or Benzonase did not inhibit co-immunoprecipitation of Treslin and Chk1, which 
rules out bridging of these proteins by DNA (Figure S1). Finally, to address whether this 
binding required phosphorylation, we treated the anti-Chk1 immunoprecipitates with lambda 
phosphatase. Although the phosphatase treatment appeared to be effective, as indicated by 
increased electrophoretic mobility of Treslin, we observed no decrease in binding of Chk1 to 
Treslin (Figure 1C). Overall, we conclude that Chk1 associates specifically with Treslin in 
human cells.
Mapping of the Chk1-interacting Domain in Treslin
To investigate the molecular basis of this interaction, we set out to map a Chk1-interacting 
region in Treslin. We engineered various sub-fragments of the 1253-1909 fragment, 
expressed them in human cells, performed S-protein pulldowns, and immunoblotted for 
Chk1. We found that approximately 100 amino acids at the C-terminal end of the protein 
were necessary for binding to Chk1 (Figures 2A and 2B). We proceeded to show that a 100 
amino acid fragment from the C-terminal end (residues 1810-1909) was also sufficient for 
binding. The sequence of this region is well conserved in the Xenopus and zebrafish 
homologues of Treslin (Figure 2C). Accordingly, we named this region the TRCT (Treslin 
C-terminal) domain.
To characterize the TRCT, we prepared this domain as a GST fusion protein (Figure 2D). 
The purified GST-TRCT bound well to Chk1 in human cell lysates. By contrast, GST-
tagged sub-fragments of this region (e.g., residues 1810-1872 and 1870-1909) did not 
associate with Chk1 significantly, which suggests that the whole domain is necessary for 
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binding. The most conserved stretch within the human TRCT corresponds to the sequence 
LTQSPLL at positions 1846-1852. This sequence is identical in Xenopus and zebrafish 
homologues of Treslin, but is not present in budding yeast Sld3. We mutated each residue in 
this sequence to alanine (to create the 7A mutant) in the context of both the GST-TRCT 
construct and the full-length Treslin-SF protein. We found that 7A-mutant versions of these 
polypeptides were completely defective for binding to Chk1 (Figures 2D and 2E). Notably, 
the 7A mutant of full-length Treslin bound TopBP1 normally. We also identified three 
residues within the TRCT (S1887, S1893, and T1987) that sit in consensus sequences for 
phosphorylation by Chk1 (RXXS/T). However, mutation of any one of these residues to 
alanine had no effect on the binding to Chk1 (Figure 2D). Finally, we assessed whether 
Treslin associates with Chk1 directly. For this purpose, we incubated the TRCT domain with 
purified, recombinant Chk1 (Figure S2). We observed that the WT TRCT bound to isolated 
Chk1 very efficiently, whereas there was virtually no binding of the 7A mutant. Since no 
phosphorylation could occur under these conditions, this observation reinforces the concept 
that phosphorylation of the TRCT is not necessary for binding to Chk1. Overall, these 
results indicate that Chk1 associates directly in a highly specific manner with sequences in 
the C-terminal region of Treslin.
The TRCT Domain Promotes Chk1-catalyzed Phosphorylation of Treslin
One explanation for the binding of Chk1 to the TRCT would be that it facilitates 
phosphorylation of Treslin by Chk1. To address this possibility, we first examined whether 
Treslin could serve as a substrate of Chk1. We initially tested the GST-TRCT construct and 
found wild-type (WT) recombinant Chk1 but not kinase-dead (KD) Chk1 could 
phosphorylate this fragment well (Figure 3A). By contrast, there was no phosphorylation of 
the mutant GST-TRCT-7A fragment by Chk1 above background levels. The S1893A and 
T1897A mutants of the TRCT domain showed reduced phosphorylation by Chk1, while the 
S1887A mutant was still an equally good substrate. A combined S1893A/T1897A mutant 
displayed near background levels of phosphorylation by Chk1 (Figure S3A), which suggests 
that these positions are the two main in vitro phosphorylation sites within this domain. As 
anticipated, this mutant also still bound normally to Chk1 (Figure S3B). Phosphorylation of 
the TRCT domain by Chk1 appears to be quite efficient. For comparison, phosphorylation of 
a GST-tagged peptide from Cdc25 that contains a single well-documented site for Chk1 
(Kumagai et al., 1998) was about 2-fold lower (Figure S3C). Finally, we likewise examined 
full-length Treslin and found that the WT but not 7A-mutant protein could serve as good 
substrate for Chk1 (Figures 3B and 3C). Taken together, these results indicate that docking 
of Chk1 onto the TRCT domain strongly stimulates phosphorylation of Treslin by Chk1.
We employed mass spectrometry to identify in vitro phosphorylation sites for Chk1 on full-
length Treslin. This analysis resulted in the identification of numerous sites throughout 
much of the protein (not shown). For these studies, we decided to focus on using the 7A 
mutant to investigate the functional significance of the Treslin-Chk1 interaction. This 
mutant is not an effective substrate for Chk1 in vitro and most likely in vivo. Furthermore, 
this approach would also address the possibility that the physical association of Chk1 with 
Treslin may also have a regulatory impact apart from phosphorylation.
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Binding of Treslin Is Not Essential for Activation of Chk1
We previously demonstrated that ablation of Treslin from human cells compromises both 
DNA replication and phosphorylation of Chk1 upon treatment with aphidicolin (APH) 
(Kumagai et al., 2010). In principle, the latter defect could reflect a direct role for Treslin in 
the activation of Chk1. Alternatively, this effect could be indirectly due to the absence of 
replication forks in cells without Treslin. Because Treslin associates with Chk1, we asked 
whether Treslin is directly necessary for activation of Chk1 in APH-treated cells. For this 
purpose, we utilized lines of U2OS cells in which expression of siRNA-resistant versions of 
WT and 7A Treslin was under the control of a doxycycline-inducible promoter (see 
Experimental Procedures). To characterize these cell lines, we first used labeling with EdU 
to assess whether the 7A mutant could rescue DNA replication in Treslin siRNA-treated 
cells. We found that the percentages of EdU-positive nuclei were similar for Treslin-ablated 
cells expressing WT or 7A Treslin (Figure 3D).
Next, we examined phosphorylation of Chk1 in cells treated with APH. As expected, 
treatment of the parental U2OS cell line with APH in the presence of control siRNA 
efficiently induced the phosphorylation of Chk1 on S345 (Figure 3E). As described 
previously, treatment with Treslin siRNA resulted in markedly reduced phosphorylation of 
Chk1. We proceeded to show that expression of either WT or 7A siRNA-resistant Treslin 
could efficiently rescue phosphorylation of Chk1 in APH-treated cells that had been treated 
with the Treslin siRNA. These observations indicate that the binding of Chk1 to the TRCT 
domain is not essential for activation of Chk1 in response to APH.
The Isolated TRCT Domain of Treslin Stimulates DNA Replication in Xenopus Egg Extracts
We next considered the possibility that Chk1 regulates DNA replication by associating with 
the TRCT domain. As one approach to examine this question, we utilized various types of 
extracts from Xenopus eggs that recapitulate DNA replication in a cell-free reaction. In 
particular, we utilized the nucleoplasmic extract (NPE) system, in which replication occurs 
in a soluble nuclear fraction lacking membranes (Walter and Newport, 2000). We also used 
whole egg extracts in which DNA replication takes place in reconstituted nuclei.
We reasoned that the isolated TRCT domain might act as a competitor of the interaction 
between endogenous Treslin and Chk1 in egg extracts. To explore this possibility, we added 
the GST-TRCT to the NPE system and then monitored the time-course of DNA replication. 
For this purpose, we assessed incorporation of radioactive phosphate from [α-32P]dATP into 
chromosomal DNA. We observed that addition of the TRCT fragment elicited a significant 
increase in DNA replication in comparison with samples treated with control buffer alone or 
the mutant TRCT-7A fragment (Figures 4A and 4B).
To assess whether this replication occurs by the normal CDK-mediated mechanism, we 
utilized the CDK inhibitor p27 (Figure 4C). We noted that there was no DNA replication in 
p27-treated extracts in either the presence or absence of the TRCT domain. To gauge 
whether the TRCT does actually prevent the binding of Chk1 to endogenous Treslin, we 
performed immunoprecipitation experiments with anti-Chk1 antibodies (Figure 4D). We 
could readily detect Treslin in anti-Chk1 immunoprecipitates from NPE fractions. 
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Association of Treslin with Chk1 was not inhibited by treatment with ethidium bromide or 
Benzonase, agents that would prohibit bridging by DNA (Figure S4A). We observed that 
addition of the WT TRCT fragment to NPE fractions caused a severe reduction in the 
binding of Treslin to Chk1, whereas the 7A mutant fragment had no effect. By contrast, the 
TRCT domain had no effect on the binding of Treslin to TopBP1. Overall, these results 
indicated that blockage of the binding of Chk1 to Treslin results in elevated DNA 
replication.
Chk1 Regulates DNA Replication in Xenopus Egg Extracts
As another means to investigate the regulation of DNA replication by Chk1, we utilized the 
Chk1 inhibitor AZD7762. We found that this compound also elicited an increase in DNA 
replication comparable to that induced by the TRCT-WT fragment (Figure 4E and Figure 
S4B). We also attempted to immunodeplete Chk1 from the NPE system, which entails 
separate immunodepletion from the HSS and NPE fractions that are necessary for these 
experiments. However, these immunodepletion procedures resulted in a non-specific 
reduction of replication, which confounded this approach.
As an alternative, we attempted to deplete Chk1 from whole egg extracts (Kumagai et al., 
1998). We first needed to assess whether the TRCT affects replication in whole egg extracts, 
which would require transport of the TRCT into reconstituted nuclei in these extracts. Since 
our initial GST construct lacked a nuclear localization sequence (NLS), we prepared a new 
construct with this sequence (GST-TRCT-NLS) (Figure 5A). We verified that both WT and 
7A versions of the TRCT-NLS could be found in lysates of reconstituted nuclei from whole 
egg extracts. Unexpectedly, the WT but not 7A version of the TRCT-NLS also caused a 
dramatic accumulation of Chk1 in the nuclei (Figure 5B). A plausible explanation is that the 
TRCT-NLS, because of its robust binding to Chk1, may promote nuclear entry of Chk1.
Next, we added the WT TRCT-NLS to whole egg extracts containing reconstituted nuclei 
and found that this fragment also elicited an increase in DNA replication relative to 
incubations containing control buffer or a 7A mutant version of the TRCT-NLS (Figures 5C 
and 5D). Finally, we removed Chk1 from whole egg extracts with anti-Chk1 antibodies 
(Figure 5E). We observed a significant acceleration of DNA replication in Chk1-depleted 
extracts (Figures 5F and 5G). Furthermore, addition of recombinant Chk1 to the depleted 
extracts restored replication to the lower level found in mock-depleted extracts. Taken 
together, these experiments provide multiple lines of evidence that Chk1 regulates DNA 
replication in the Xenopus system.
The Isolated TRCT Domain Promotes Initiation of Replication in Egg Extracts
A key function of Treslin involves the loading of Cdc45 onto chromatin (Kumagai et al., 
2010). It has been well established that the loading of Cdc45 is critical for the initiation of 
DNA replication in both yeast and vertebrates (Sclafani and Holzen, 2007; Siddiqui et al., 
2013; Tanaka and Araki, 2013). To explore the basis of the TRCT-mediated stimulation of 
replication, we examined the loading of Cdc45 onto chromatin in the NPE system in the 
presence of this fragment. We observed that addition of the TRCT-WT protein stimulated a 
large increase in the loading of Cdc45 onto chromatin in comparison with samples 
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containing the TRCT-7A protein (Figure 6A). There was a similar increase in the loading of 
Sld5 (a component of GINS), PCNA, and DNA polymerase epsilon (Figure S5). The TRCT 
domain typically did not affect the binding of the ORC and MCM complexes to the DNA. 
These experiments suggest that the isolated TRCT domain promotes initiation by 
stimulating the loading of the helicase activators Cdc45 and GINS onto chromatin. 
Furthermore, we also observed an increase other replication-fork proteins, such as PCNA 
and DNA polymerase epsilon, which participate directly in the ensuing DNA synthesis.
As another method to characterize this phenomenon, we attempted to block replication just 
after initiation. Actinomycin D blocks replication in the NPE system shortly after initiation 
but before significant unwinding of the DNA (Pacek and Walter, 2004). Accordingly, we 
added actinomycin D to the NPE system in the absence and presence of the TRCT domain. 
We found that actinomycin D caused a pronounced further accumulation of Cdc45 on the 
DNA in extracts containing the WT TRCT domain (Figure 6B). There was no effect in 
extracts containing the TRCT-7A mutant. Taken together, these experiments suggest that the 
TRCT domain promotes the initiation of replication. The fact that the TRCT domain blocks 
the binding of Chk1 to Treslin suggests that Chk1 suppresses the initiating function of 
Treslin.
To obtain further support for this concept, we performed DNA fiber studies in whole egg 
extracts following addition of the TRCT domain. For this purpose, we incubated extracts 
sequentially with digoxigenin-dUTP and biotin-16-dUTP, prepared DNA fibers from 
nuclear fractions, and then measured inter-origin distances (Bellelli et al., 2014; Marheineke 
et al., 2009). We observed that the WT TRCT fragment caused a significant increase in 
shorter inter-origin distances (e.g., 10–15 kb) relative to incubations containing added buffer 
alone or the 7A fragment (Figure 6C; Figures S6A and S6B). Concomitantly, there was a 
decrease in larger inter-origin distances (e.g., >30 kb) in incubations containing the WT 
fragment. These findings directly support an increase in the firing of origins, which fits well 
with the observations that the TRCT domain enhances formation of the activated replicative 
helicase.
Dysregulated Origin Firing in the Absence of the Treslin-Chk1 Interaction Induces 
Activation of Chk1
The elevated loading of Cdc45 onto chromatin and the ensuing increase in replication in the 
presence of the TRCT domain raised the possibility that this fragment might elicit 
replication stress. To address this issue, we examined phosphorylation of Xenopus Chk1 on 
S344 (Kumagai et al., 1998). We observed that the WT TRCT domain induced 
phosphorylation of Chk1 in NPE fractions containing sperm chromatin even in the absence 
of APH (Figure 6D). The TRCT domain also caused a substantial further increase in 
phosphorylation of Chk1 in extracts containing APH. By contrast, there was no increase in 
extracts treated with control buffer or the 7A mutant TRCT domain. Furthermore, the 
increase in the presence of the WT TRCT domain was abolished by caffeine, an inhibitor of 
the ATR-catalyzed phosphorylation of Chk1. Therefore, the TRCT-stimulated activation of 
Chk1 involves the ATR-mediated pathway. This increase also depended on the presence of 
sperm chromatin as a template for replication, which suggests that the TRCT domain does 
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not somehow directly activate Chk1 by a DNA-independent mechanism. In further support 
of this concept, we found that inhibition of DNA replication with p27 abolished the TRCT-
stimulated increase in the phosphorylation of Chk1 in extracts lacking APH (Figure S6C). 
Overall, these experiments indicate that the isolated TRCT domain causes a pronounced 
derangement of DNA replication in the Xenopus egg extract system.
Expression of the Treslin-7A Mutant in Human Cells Leads to Increased Origin Firing
As another strategy to examine the function of the Treslin-Chk1 interaction, we utilized 
human cells that overexpress the Treslin-7A mutant. In particular, we employed U2OS T-
REx cells that express WT and 7A Treslin in a doxycycline-inducible manner. We induced 
the expression of Treslin in these cells by addition of doxycycline and later examined origin 
firing by DNA fiber analysis (Jackson and Pombo, 1998; Schlacher et al., 2011). For these 
studies, we incubated the cells with CldU for 20 min and then with IdU for 20 min (Figure 
7A). Next, we prepared DNA fibers from the cells by standard methods and detected 
incorporation of the modified nucleotides with fluorescently tagged antibodies that detect 
CldU (green tracks) and IdU (red tracks). Finally, we quantitated the frequency of singly 
labeled IdU (red) tracks as a measure of new origin firing during the second labeling period. 
We noted that there was a significant increase in origin firing in cells expressing the full-
length Treslin-7A mutant in comparison with cells expressing the WT protein (Figures 7B–
7D). The induced levels of the WT and 7A proteins were quite similar in the different cell 
lines. Moreover, overexpression of WT Treslin did not have a significant effect on origin 
firing. We also examined replication fork speed in these cells but could not discern a 
difference between cells expressing WT or 7A Treslin (Figure S7). Overall, these 
experiments further support our findings with Xenopus egg extracts that disruption of the 
Treslin-Chk1 interaction leads to increased origin firing. The fact that the Treslin-Chk1 
interaction is functionally important in both Xenopus and humans suggests that this 
regulatory mechanism is a conserved feature of DNA replication in vertebrates.
DISCUSSION
In this report, we have identified an interaction between Treslin and the key checkpoint-
effector kinase Chk1. The high specificity of this binding suggested that there is a significant 
regulatory relationship between these two proteins. Indeed, we have found that Chk1 
negatively regulates the replication-initiating function of Treslin (see Figure 7E). To reach 
this conclusion, we utilized both Xenopus egg extracts and human cells. In one approach, we 
added the TRCT domain from Treslin to Xenopus egg extracts as a competitor of the 
Treslin-Chk1 interaction. Strikingly, this peptide elicited a pronounced increase in DNA 
replication.
In searching for the basis of this phenomenon, we found that the TRCT fragment strongly 
stimulated the binding of Cdc45 to chromatin. The loading of Cdc45 onto chromatin in egg 
extracts is rate limiting for origin firing (Mimura et al., 2000; Walter and Newport, 2000). 
Thus, the TRCT domain appears to act by enhancing initiation. To provide further evidence, 
we have dissected this process with actinomycin D, a drug that blocks replication in egg 
extracts just after initiation but before significant unwinding of the DNA (Pacek and Walter, 
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2004). Treatment with both the TRCT domain and actinomycin D led to a dramatic and 
sustained accumulation of Cdc45 on chromatin. Finally, we utilized DNA fiber studies to 
show that the addition of the TRCT domain to egg extracts leads to an overall decrease in 
inter-origin distances in replicating chromatin.
In a complementary approach, we also employed human cells. In particular, we also used 
DNA fiber analysis to show that human cells overexpressing the full-length Treslin-7A 
mutant display increased origin firing during an unperturbed S-phase. This observation is 
consistent with the fact that human cells with compromised function of Chk1 display 
elevated firing of replication origins during a normal cell cycle (Maya-Mendoza et al., 2007; 
McIntosh and Blow, 2012; Miao et al., 2003; Syljuasen et al., 2005). Hence, our studies 
have revealed a mechanism by which Chk1 controls replication in cells without overtly 
damaged DNA. It has also been reported that Chk1-deficient cells display decreased 
replication-fork speed (see Petermann et al., 2010). We have not observed an obvious effect 
on fork speed in cells expressing the Treslin-7A mutant. This mutant may not cause enough 
origin firing to disrupt fork progression. Moreover, Chk1 could have distinct targets for 
initiation versus elongation.
Utilization of replication origins places a number of regulatory demands on cells. The firing 
of origins depends upon positive regulation of Treslin by S-CDK, but there may also have to 
be negative regulatory mechanisms that suppress premature or inappropriate action of 
Treslin at origins. The ability of Chk1 to inhibit the Treslin-mediated loading of Cdc45 
would provide such a mechanism. This process could operate generally at all origins or 
come into play at a subset of origins under certain circumstances.
Typically, the number of loaded MCM complexes on chromatin at the onset of S-phase 
greatly exceeds the number of origins that actually fire in a given cell cycle. This “MCM 
paradox” has suggested that there are a large number of dormant origins in the genome (see 
McIntosh and Blow, 2012). It has been proposed that utilization of these dormant origins 
would allow cells to cope with replication stress by increasing the likelihood that replication 
in stressed areas would reach completion. The question arises, however, about how the cell 
would regulate the firing of such dormant origins under both unstressed and stressed 
conditions. It has been postulated that these origins might fire stochastically such that 
passive replication from nearby origins would typically occur under unstressed conditions. 
However, under stressed conditions of slowed or blocked replication, there would be more 
time for the dormant origins to undergo firing.
Another type of explanation would incorporate the existence of an inhibitory mechanism 
that suppresses firing of dormant origins. In principle, inhibition of Treslin-mediated loading 
of Cdc45 by basally active Chk1 under unstressed conditions could correspond to such a 
mechanism. Our DNA fiber studies with egg extracts do not suggest that there is rampant 
firing of dormant origins upon addition of the TRCT domain. However, more limited firing 
of dormant origins may contribute to the accelerated replication that we have observed under 
these conditions.
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The Treslin-Chk1 interaction might also help to explain the temporal order in firing of 
origins during S-phase in somatic cells. In eukaryotic cells, there is typically a pattern 
wherein “early” and “late” origins at distinct chromosomal regions fire at different times 
(McIntosh and Blow, 2012; Siddiqui et al., 2013). In budding yeast, regulation of the Treslin 
homologue Sld3 has a role in the distinction between early and late origins (Lopez-
Mosqueda et al., 2010; Zegerman and Diffley, 2010). However, the mechanisms that 
regulate such differential firing in vertebrates are largely unknown. Another potential 
explanation for the inhibition of Treslin by Chk1 is that this process could be necessary for 
the suppression of later-firing origins during the earlier parts of S-phase. Further studies will 
be required to identify the characteristics of origins that are subject to Chk1-dependent 
inhibition of Treslin.
It is well accepted that the ATR-dependent activation of Chk1 in response to incompletely 
replicated and damaged DNA leads to inhibition of origin firing at chromosomal regions that 
are not already engaged in replication (McIntosh and Blow, 2012; Sorensen and Syljuasen, 
2012; Yekezare et al., 2013). The activation of Chk1 results in decreased function of Cdc25 
and increased function of Wee1 (Perry and Kornbluth, 2007). In turn, these effects promote 
the inhibitory phosphorylation of Cdk2 (as well as Cdk1) on T14 and Y15. The loading of 
Cdc45 onto chromatin requires phosphorylation of Treslin by Cdk2, which mediates binding 
of Treslin to TopBP1 (Boos et al., 2011; Kumagai et al., 2011). Therefore, it might be 
anticipated that reduced activity of Cdk2 would compromise formation of the Treslin-
TopBP1 complex. Indeed, treatment of human cells with hydroxyurea reduces the binding of 
Treslin to TopBP1, and the Chk1 inhibitor AZD7762 reverses this effect (Boos et al., 2011).
We have not been able to detect an override of the hydroxyurea-induced block to replication 
in U2OS cells expressing the Treslin-7A mutant (not shown). This mutation would 
presumably not affect the ability of Chk1 to down-regulate Cdk2. We have also observed 
that both the WT and 7A forms of Treslin bind equally well to TopBP1. Moreover, the 
Treslin-7A mutant displays normally regulated binding to TopBP1 (i.e., decreased binding 
in the presence of hydroxyurea) (not shown). Finally, the TRCT domain does not affect 
binding of Treslin to TopBP1 in Xenopus NPE fractions. It would be interesting to examine 
the effect of the Treslin-7A mutant in replication-stressed cells in which the inhibition of 
Cdk2 had been overridden.
Although inhibition of Cdk2 could account for the effect of Chk1 on DNA replication in 
stressed cells, it is unclear that this mechanism could explain the role of Chk1 in unstressed 
cells. The activity of Cdk2 rises substantially at S-phase in unperturbed cells. It is possible 
that there could be some local inhibition of Cdk2 in certain regions of the genome, but the 
mechanistic basis for such an effect is unknown. Another explanation is that Chk1 could 
control replication in some other manner besides regulation of Cdk2 under conditions where 
there is not a strong, exogenous threat to the DNA. The regulation of Treslin by Chk1 may 
be such a mechanism. It should also be noted that our studies do not rule out the possibility 
that Chk1 could have an additional target(s) besides Treslin during an unperturbed S-phase. 
Overall, inhibition of Treslin by Chk1 could suppress relevant origins during an unperturbed 
S-phase and perhaps even supplement the inhibition of Cdk2 in replication-stressed cells.
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A previous study in the Xenopus system indicated that depletion of Chk1 did not increase 
DNA replication in either untreated or APH-treated egg extracts (Luciani et al., 2004). For 
the untreated extracts, these investigators quantitated DNA replication at a single late time 
point (120 min) when replication would have reached completion. Hence, this analysis 
would not have detected the early acceleration of replication that we have observed in this 
study. Another group found that the Chk1 inhibitor UCN-01 did not increase replication in 
egg extracts, but actually inhibited replication to some extent (Murphy and Michael, 2013). 
However, UCN-01 also inhibits Cdk2 at the concentrations used in this study (Kawakami et 
al., 1996), which complicates interpretation of the results.
In principle, phosphorylation of Treslin by Chk1 may alter its conformation or directly 
affect its interactions with other proteins to preclude helicase activation. Moreover, the 
physical association of Chk1 might also have such effects on Treslin. Regulation by Chk1 
appears not to reduce binding of Treslin to TopBP1, but Chk1 may nonetheless alter the 
helicase-activating properties of this complex. Chk1 may also inhibit the ability of Treslin 
and TopBP1 to recognize Cdc45/GINS effectively or deliver Cdc45/GINS to the MCM 
complex. Finally, Chk1 may influence the interaction of Treslin with some other 
component(s) of the replication apparatus. We will need to understand better the exact 
molecular mechanism by which Treslin promotes helicase activation in order to evaluate 
which, if any, of these possibilities is correct.
In conclusion, we have used both the Xenopus and human systems to provide new 
perspectives on the function of Chk1 and the regulation of early steps in DNA replication. 
Further analysis of this process may yield additional insights into how vertebrate cells 
ensure the faithful propagation of their genomes.
EXPERIMENTAL PROCEDURES
Plasmids
The cDNA for human Treslin (GenBank ADC30133.1) was described before (Kumagai et 
al., 2010). pcDNA5/TO-Treslin-SF (encoding the SV40 NLS, an S-peptide tag, and a 3X-
FLAG tag at the C-terminal end of Treslin) was created from pcDNA5/TO-Treslin-Myc by 
using PCR to exchange tags (Kumagai et al., 2011).
Human Tissue Culture Cells
293T and U2OS cells were cultured in DMEM containing 10% fetal bovine serum. 293T 
cells were transfected using FuGENE6. Large-scale transfections as well as preparation of 
nuclear lysates are described in Supplemental Experimental Procedures.
Antibodies
Anti-Treslin antibodies were previously described (Kumagai et al., 2010). For other 
antibodies, see Supplemental Experimental Procedures.
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Mass spectrometry analysis
Plasmids encoding different versions of Treslin-SF were transfected into 293T cells. Tagged 
proteins were reisolated and analyzed by mass spectrometry as described in Supplemental 
Experimental Procedures. Binding of Chk1 to full-length Treslin was established by 
matching 9 unique peptides that covered 24% of the sequence of Chk1. For binding to the 
1253-1909 C-terminal fragment, we detected 10 unique peptides also covering 24% of the 
sequence. There was no binding of Chk1 to the 1-1257 N-terminal fragment.
Recombinant GST fusion proteins
To produce GST and GST-NLS fusion proteins containing versions of the human TRCT, 
appropriate DNA was amplified by PCR and cloned into pGEX4T-3 or pGEX-NLS, 
respectively. Proteins were produced as described in Supplemental Experimental 
Procedures.
Production of U2OS cell lines expressing Treslin and its mutants
U2OS T-REx cells were maintained, transfected with pcDNA5/TO encoding siRNA-
resistant Treslin, and selected as described (Kumagai et al., 2011). Single colonies that 
expressed the desired protein upon addition of doxycycline were isolated for analysis.
siRNA Experiments
Stealth siRNA specific for Treslin (#2, AGGACACAUUCUGCCUCCUUCUAUU) and 
control siRNA (low GC) were obtained from Invitrogen. The siRNA (30 nM) was 
transfected into U2OS cells with Lipofectamine RNAiMAX (Invitrogen). For rescue 
experiments, pcDNA5/TO-Treslin-SF was rendered resistant to siRNA #2. We obtained 
more efficient rescue by using siRNA #2 instead of the previous siRNA #1 (Kumagai et al., 
2010).
Xenopus Egg Extracts
Whole extracts from Xenopus eggs were prepared as before (Kumagai et al., 2010). 
Preparation of nuclear lysates, immunodepletion of Chk1, and DNA replication assays were 
also described previously (Kumagai et al., 1998; Kumagai et al., 2010). Further details are 
provided in Supplemental Experimental Procedures.
Xenopus NPE System
Nucleoplasmic extract (NPE) and high-speed supernatant (HSS) from Xenopus eggs were 
prepared as described (Lebofsky et al., 2009). Details on the use of these extracts for assays 
of DNA replication and binding to chromatin are described in Supplemental Experimental 
Procedures.
DNA fiber assays
Xenopus egg extracts were incubated sequentially with digoxigenin-11-dUTP and biotin-16-
dUTP. Labeled DNA fibers were prepared as described (Bellelli et al., 2014; Marheineke et 
al., 2009). Human U2OS cells were labeled with 40 μM CldU, washed with phosphate-
buffered saline (PBS), and finally labeled with 50 μM IdU as indicated in figures. 
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Preparation of DNA fiber spreads was reported previously (Jackson and Pombo, 1998; 
Schlacher et al., 2011). Further details on these protocols are provided in Supplemental 
Experimental Procedures.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Identification of Chk1 as a Treslin-interacting Protein in Human Cells
(A) Procedure for isolation of Treslin-interacting proteins.
(B) Nuclear lysates from 293T cells expressing tag only (lanes 1 and 5) or indicated forms 
of Treslin-SF (lanes 2–4 and 6–8) were incubated with S-protein agarose (lanes 1–4). Beads 
were immunoblotted with anti-TopBP1 (top), anti-Chk1 (middle), and anti-FLAG (bottom). 
Input lysates, lanes 5–8.
(C) Nuclear lysates from 293T cells were incubated with control IgG (lanes 2, 5, and 8) or 
antibodies against Chk1 (lanes 3, 9, 10, and 11) or Treslin (lane 6) bound to magnetic beads. 
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In right panel, bead-bound anti-Chk1 immunoprecipitates (lanes 9–11) were either left on 
ice (lane 9) or incubated without (lane 10) or with 20 U/μl lambda phosphatase (lane 11) for 
30 min at room temperature. Immunoprecipitated proteins and input lysates were 
immunoblotted for Treslin (top) and Chk1 (bottom). See also Figure S1 and Table S1.
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Figure 2. Mapping of the Region in Treslin that Associates with Chk1
(A) Indicated deletion mutants of Treslin were expressed in 293T cells. Nuclear lysates were 
incubated with S-protein agarose. Bound proteins and nuclear lysates were immunoblotted 
with anti-Chk1 (top) and anti-FLAG (bottom).
(B) Abilities of various fragments of Treslin to interact with Chk1. Data from panels A and 
D; interacting fragments shown in bold.
(C) Amino acids 1810-1909 of human Treslin and corresponding portions of the X. laevis 
and zebrafish proteins were aligned with the Clustal Omega program. Amino acids with 
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asterisks (S1887, S1893, and T1897) or a line (1846-LTQSPLL-1852) were subjected to 
mutagenesis.
(D) GST only (lane 2), GST-tagged TRCT (lane 3), TRCT containing mutations S1887A 
(lane 4), S1893A (lane 5), T1897A (lane 6), or 7A (lane 7), and GST-tagged forms of 
residues 1810-1872 (lane 8) and 1870-1909 from Treslin (lane 9) were isolated from 
bacteria with glutathione agarose. Bead-bound fragments were incubated with 293T nuclear 
lysates. Beads were processed for immunoblotting with anti-Chk1 (top) and staining with 
Coomassie blue (bottom). Lane 1, input nuclear lysate.
(E) Nuclear lysates from 293T cells expressing SF tag only (lanes 1 and 5) or indicated 
forms of Treslin-SF (lanes 2–4 and 6–8) were incubated with S-protein agarose. Input 
lysates (lanes 1–4) and retrieved bead fractions (lanes 5–8) were immunoblotted as 
indicated. See also Figure S2.
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Figure 3. The TRCT Domain Promotes the Phosphorylation of Treslin by Chk1
(A) GST (lanes 1–2), GST-TRCT (lanes 3–4), and versions of this fragment containing the 
S1887A (lanes 5–6), S1893A (lanes 7–8), T1897A (lanes 9–10), or 7A mutations (lanes 11–
12) were incubated with recombinant WT Chk1 (lanes 1, 3, 5, 7, 9, and 11) or KD Chk1 
(lanes 2, 4, 6, 8, 10, and 12). See Supplemental Experimental Procedures for more details. 
Reactions were processed for phosphorimaging (top) and Coomassie blue staining (bottom).
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(B) Nuclear lysates from human 293T cells expressing SF tag only (lane 1), full-length 
Treslin-SF WT (lane 2), or Treslin-SF 7A (lane 3) were processed for purification with anti-
FLAG beads. Beads were stained with Coomassie blue.
(C) Control (lanes 1–2), Treslin-SF WT (lanes 3–4), and Treslin-SF 7A (lanes 5–6) were 
incubated with WT Chk1 (lanes 1, 3, and 5) or KD Chk1 (lanes 2, 4, and 6) in kinase buffer. 
Reactions were processed for phosphorimaging.
(D) Parental U2OS T-REx cells and T-REx cells harboring either WT or 7A siRNA-resistant 
Treslin were cultured with doxycycline. Cells were treated with either control or Treslin 
siRNA. At 72 hr, cells were labeled with 10 μM EdU for 1 hr. EdU incorporation was 
determined with the Click-iT reaction and Alexa 488 dye (Kumagai et al., 2010). Error bars, 
mean ± S.E.M. (n=3).
(E) T-REx cells (lanes 1–4) and T-REx cells harboring siRNA-resistant WT (lanes 5–8) or 
7A Treslin (lanes 9–12) were cultured with doxycycline. Cells were also treated with either 
control siRNA (lanes 1–2, 5–6, and 9–10) or Treslin siRNA (lanes 3–4, 7–8, and 11–12). At 
72 hr, cells were incubated in the absence (lanes 1, 3, 5, 7, 9, and 11) or presence of 10 
μg/ml APH (lanes 2, 4, 6, 8, 10, and 12) for 30 min. Cell lysates were immunoblotted as 
indicated. See also Figure S3.
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Figure 4. The Isolated TRCT Domain Stimulates DNA Replication in the Xenopus NPE System
(A) HSS was incubated without (lanes 1–2) or with sperm nuclei (lanes 3–10) for 30 min. 
NPE and either WT (lanes 1, 3, 5, 7, and 9) or 7A TRCT (lanes 2, 4, 6, 8, and 10) were 
added to HSS. Final concentration of TRCT was 60 ng/μl. Replication was assessed by 
incorporation of 32P from [α-32P]dATP at indicated times.
(B) Quantitation of the data from panel A and similar experiments (4–6 total). Results for 
TRCT WT and 7A were compiled from six independent experiments. Data was normalized 
to replication in the presence of TRCT WT at 90 min (***, p < 0.001). Error bars, S.E.M.
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(C) Similar as in (A), except in some cases NPE was pre-treated with 1 μM GST-p27 (lanes 
4 and 8).
(D) NPE incubated for 30 min with buffer only (lanes 2, 3, and 6) or 60 ng/μl WT (lanes 4 
and 7) or 7A TRCT (lanes 5 and 8). Samples were immunoprecipitated with control IgG 
(lane 2), anti-Chk1 (lanes 3–5), or anti-Treslin antibodies (lanes 6–8) bound to protein A 
magnetic beads. Beads were processed for immunoblotting with anti-Treslin (top), anti-
TopBP1 (middle), and anti-Chk1 (bottom). NPE (0.5 μl) was loaded in lane 1.
(E) Quantitation of data from seven independent experiments on replication in the NPE 
system with added buffer alone or 0.5 μM AZD7762. Data was normalized to replication in 
the presence of AZD7762 at 90 min (**, p < 0.01; ***, p < 0.001). Error bars, S.E.M. See 
also Figure S4.
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Figure 5. Depletion of Chk1 from Egg Extracts Also Stimulates DNA Replication
(A) Coomassie blue staining of purified GST-TRCT-NLS WT (lane 1) and 7A (lane 2).
(B) Egg extracts containing added buffer only (lane 1) or 75 ng/μl of either WT TRCT-NLS 
(lane 2) or 7A TRCT-NLS (lane 3) were incubated with sperm nuclei for 90 min. Nuclear 
lysates were immunoblotted for Treslin (top), Chk1 (middle), and GST (bottom).
(C) Egg extracts were supplemented with buffer only (lanes 1–3), 75 ng/μl WT TRCT-NLS 
(lanes 4–6), or 7A TRCT-NLS (lanes 7–9). DNA replication was measured at indicated 
times.
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(D) Quantitation of the data from (C) and two additional experiments (mean ± S.E.M.). 
Paired Student’s t-tests for extracts treated with WT TRCT-NLS versus extracts treated with 
buffer only or 7A TRCT-NLS yielded p values < 0.001.
(E) Egg extracts were either mock-depleted with control IgG (lane 1) or depleted with anti-
Xenopus Chk1 antibodies (lanes 2 and 3). His6-Chk1 was added back to Chk1-depleted 
extract (lane 3).
(F) The extracts from panel E were assayed for chromosomal DNA replication.
(G) Quantitation of the data from (F) and two additional experiments (mean ± S.E.M.). 
Paired Student’s t-tests for Chk1-depleted extracts versus mock-depleted and Chk1-depleted 
extracts containing recombinant Chk1 yielded p values < 0.05.
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Figure 6. The TRCT Domain Elicits Increased Loading of Cdc45 and Dysregulated Activation of 
Chk1
(A) HSS was incubated without (lanes 1–2) or with sperm nuclei (lanes 3–10) for 30 min. 
NPE and either WT (lanes 1, 3, 5, 7, and 9) or 7A TRCT (lanes 2, 4, 6, 8, and 10) at a final 
concentration of 60 ng/μl were added to HSS. Chromatin was isolated at indicated times and 
immunoblotted with various antibodies. Xenopus ISWI served as loading control. NPE/HSS 
mixture (0.5 μl) was loaded in lanes 9–10.
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(B) Similar as in (A), except NPE was treated with 10 μM actinomycin D as indicated (lanes 
5–7).
(C) Distribution of inter-origin distances in Xenopus egg extracts containing added buffer 
alone, TRCT-NLS WT (75 ng/μl), or TRCT-NLS 7A (75 ng/μl). Results are from three 
independent experiments (mean ± S.E.M). p < 0.05 for Buffer versus WT and for WT versus 
7A in the category of 10–15 kb using Student’s t-test. p < 0.05 for Buffer versus WT and p < 
0.001 for WT versus 7A in the category of > 30 kb.
(D) HSS was incubated in the absence (lanes 1–6) or presence of sperm nuclei (lanes 7–14) 
for 30 min. NPE lacking (lanes 1–3, 7–9, and 13) or containing 50 μg/ml APH (lanes 4–6, 
10–12, and 14) and buffer (lanes 1, 4, 7, and 10), TRCT WT (lanes 2, 5, 8, 11, 13, and 14), 
or TRCT 7A (lanes 3, 6, 9, and 12) were added to HSS. Final concentration of TRCT was 60 
ng/μl. Mixtures were incubated for 90 min in the absence (lanes 1–12) or presence of 5 mM 
caffeine (lanes 13–14). Reactions were immunoblotted with anti-P-Chk1 (top), anti-Chk1 
(middle) and anti-GST (bottom). See also Figures S5 and S6.
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Figure 7. Overexpression of the Treslin-7A Mutant in Human Cells Elicits Increased Initiation of 
Replication
(A) Schematic of DNA fiber analysis. Green tracks, CldU; red tracks, IdU. Examples of 
various types of tracts are depicted.
(B) U2OS T-Rex cells harboring Treslin WT (lanes 1 and 2) or Treslin 7A (lanes 3 and 4) 
were incubated for 48 hr in the absence (lanes 1 and 3) or presence of doxycycline (lanes 2 
and 4). Cell lysates were immunoblotted as indicated.
(C) U2OS T-Rex cells harboring Treslin WT or Treslin 7A were incubated for 48 hr in the 
absence or presence of doxycycline. Cells were labeled sequentially with CldU and IdU and 
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processed for preparation of DNA fibers as described in Experimental Procedures. Images of 
DNA fibers from doxycycline-treated cells expressing WT or 7A Treslin are shown.
(D) Summary of new origins fired during labeling with IdU. Results for induced WT and 7A 
cells were compiled from four independent experiments with two different clonal isolates 
for each construct (p < 0.001). Error bars, S.E.M.
(E) Model for the Treslin-Chk1 interaction. See Discussion for details. See also Figure S7.
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